San Jose, California (PRWEB) November 13, 2008
Reagents used in biotechnology are complex chemical compounds used in a range of biotech related areas including biochemistry, cell biology, molecular biology, immunology, protein chemistry, pharmacology, and biotechnology research. The market is dependent to a large extent on applications of biotechnology instrumentation. With the focus shifting from the gene towards the protein, disciplines such as molecular biology and protein synthesis continue to gain wide attention from the academic and commercial sectors alike. However, highly automated instrumentation is expected to temper the use of reagents. The whole spectrum of biotech, medical, and biological technologies has facilitated researchers to develop highly specialized human biological products with significant therapeutic and commercial potential. Yet, the most significant value provided by these technologies may not be limited to their end products. Greater value will be the insights provided into the disease processes.
As stated by the recent report published by Global Industry Analysts Inc, United States and Europe collectively account for a share of nearly 65% of the global biotechnology reagents market estimated in 2008. Driven by its extensive use in large-scale commercial applications, and in basic research, biotechnology reagents in Asia-Pacific are forecast to grow at the fastest CAGR of 8.75% over the period 2011 through 2015. Immunoassay reagents market represents the largest product market worldwide with revenues forecast to reach US$13.8 billion by 2012. With the present emphasis of research studies focused on determining the activation state of a protein rather than unraveling the gene, which hitherto involved the use of DNA arrays and mRNA profiling, world market for protein synthesis reagents is forecast to grow at a robust CAGR of 10.38% over the period 2011 through 2015. Driven by its increasing use in life sciences applications, liquid chromatography reagents market in the US is expected to reach US$3.4 billion by the year 2015. Biotech and pharmaceutical industries constitute the major consumers of chromatography reagents.
Key players dominating the marketplace include Abbott Diagnostics, Applied Biosystems, Beckman Coulter Inc., Becton Dickinson and Company, Biomerieux SA, Chemicon International Inc., Cortex Biochem Inc., EMD Biosciences Inc., GE Healthcare, Invitrogen Corporation, Ortho-Clinical Diagnostics, PerkinElmer Inc., Promega Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc and Sigma - Aldrich, among others.
The report titled "Biotechnology Reagents: A Global Strategic Business Report" published by Global Industry Analysts, Inc., provides a comprehensive review of market dynamics, trends, issues, and competition. The report enumerates recent product launches, innovations, developments, mergers, acquisitions and other strategic industry activities. Product segments analyzed in the study include Cell/Tissue Culture Reagents, DNA Sequencing/Synthesis Reagents, Electrophoresis Reagents, Flow Cytometry Reagents, Immunoassay Reagents, Liquid Chromatography Reagents, Polymerase Chain Reaction Reagents, and Protein Synthesis Reagents. Analysis is presented for established and emerging markets including United States, Canada, Japan, France, Germany, United Kingdom, Italy, Asia-Pacific, and Latin America.
For more details of this research report, please visit
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 700 people worldwide and publishes more than 880 full-scale research reports each year. Additionally, the company also offers a range of over 60,000 smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.
Global Industry Analysts, Inc.
Web Site http://www.StrategyR.com/